| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/12/2006 | EP1677796A2 Muscarinic acetylcholine receptor antagonists field of the invention |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1677780A2 Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism |
| 07/12/2006 | EP1677778A2 Method of treating airway diseases with beta-adrenergic inverse agonists |
| 07/12/2006 | EP1677755A2 Spill resistant formulations containing clays |
| 07/12/2006 | EP1677745A2 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 07/12/2006 | EP1677740A2 Methods and compositions for treating cancer |
| 07/12/2006 | EP1677739A2 Methods of identifying agents that inhibit the growth of cancer cells |
| 07/12/2006 | EP1677738A2 Reconstitutable microsphere compositions useful as ultrasonic contrast agents |
| 07/12/2006 | EP1677737A2 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 07/12/2006 | EP1677736A2 Product and process for increasing compactibility of carbohydrates |
| 07/12/2006 | EP1677735A2 Methods and compositions for modulating adipocyte function |
| 07/12/2006 | EP1677734A2 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 07/12/2006 | EP1677733A2 Gene expression profiles and methods of use |
| 07/12/2006 | EP1677732A2 Disinfecting teat care compositions |
| 07/12/2006 | EP1677731A2 Thiophene and benzothiophene hydroxamic acid derivatives |
| 07/12/2006 | EP1677703A2 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
| 07/12/2006 | EP1677597A2 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes |
| 07/12/2006 | EP1534749A4 Variant integrin polypeptides and uses thereof |
| 07/12/2006 | EP1504252A4 Systems and methods for blood glucose sensing |
| 07/12/2006 | EP1137392B1 Striped dentifrice |
| 07/12/2006 | EP0977594B1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 07/12/2006 | CN1802369A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 07/12/2006 | CN1802353A Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 07/12/2006 | CN1802170A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 07/12/2006 | CN1802149A Pharmaceutical composition comprising N((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800175A Amino alcohol derivatives |
| 07/12/2006 | CN1263758C 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/11/2006 | USRE39181 1 mg/ml risperidone or salt, 7.5 mg/ml tartaric acid and sufficient sodium hydroxide buffer to adjust the pH in the range from 3 to 4; and water q.s. ad 1 ml.; suitable for oral adminstration; improved physiochemical stability |
| 07/11/2006 | US7074430 Oral administering |
| 07/11/2006 | US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 07/11/2006 | US7074394 contains aluminum/zirconium chlorohydrates formed by reacting basic aluminum halides/nitrates with zirconium halides/nitrates |
| 07/06/2006 | WO2005041867A8 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
| 07/06/2006 | WO2004100878A3 Method of treatment of hemorrhagic disease using a factor viia/tissue factor inhibitor |
| 07/06/2006 | WO2004084805A3 Acetylated tat polypeptides and methods of use thereof |
| 07/06/2006 | WO2004066926A3 Methods and compositions for modulating t lymphocytes |
| 07/06/2006 | WO2004062603A3 Methods of treating lung diseases |
| 07/06/2006 | US20060149484 Absolute quantitation of nucleic acids by rt-pcr |
| 07/06/2006 | US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/06/2006 | US20060149041 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 07/06/2006 | US20060148923 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications |
| 07/06/2006 | US20060148865 Preparation of chemical compounds |
| 07/06/2006 | US20060148854 Chemical compounds |
| 07/06/2006 | US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 07/06/2006 | US20060148805 Opthalmic compositions for treating ocular hypertension |
| 07/06/2006 | US20060148803 Substituted peptides useful in the treatment of alzheimer's disease |
| 07/06/2006 | US20060148771 Medicinal compounds |
| 07/06/2006 | US20060148721 Combination therapy for the treatment of dyslipidemia |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 07/06/2006 | US20060147555 a mixture of Commiphora mukul, Boswellia serrata, Semecarpus anacardium Strychnox nux vomica, Terminalia arjuna and Shankha Bhasma |
| 07/06/2006 | US20060147547 Bone enhancing composite |
| 07/06/2006 | US20060147528 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
| 07/06/2006 | US20060147501 Collagen compositions and biomaterials |
| 07/06/2006 | US20060147498 Composition material for transmucosal delivery |
| 07/06/2006 | US20060147448 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 07/06/2006 | US20060147426 Nutrient broth comprising multipotent cells for use in propagation of mesodermal, neuroectodermal, and endodermal cells; tissue engineering |
| 07/06/2006 | US20060147416 Method of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes |
| 07/06/2006 | US20060147411 Novel compounds for the treatment of sickle cell disease |
| 07/06/2006 | US20060147400 Composition, especially a cosmetic composition, containing at least one alkyl para-hydroxybenzoate and at least one lipophilic amino acid derivative |
| 07/06/2006 | US20060147395 Active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or is cell-occlusive, so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion, therapeutic, as a prophylactic and/or as a cosmetic agent |
| 07/06/2006 | US20060146557 Make-up applicator with led light source |
| 07/05/2006 | EP1676583A2 Therapeutic agent for periodontal disease |
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1675886A2 Water-soluble polyamioamides as sunscreen agents |
| 07/05/2006 | EP1675600A2 Methods, compositions,, apparatuses containing tetrameric oxygen |
| 07/05/2006 | EP1675588A2 Use of peroxisome proliferator-activated receptor gamma (ppar gamma) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions |
| 07/05/2006 | EP1675579A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/05/2006 | EP1675572A2 Coated metal pyrithione particles for treatment of microorganisms |
| 07/05/2006 | EP1675565A1 Cosmetic composition comprising camel milk or components thereof |
| 07/05/2006 | EP1675555A2 Pharmaceutical compositions for prevention of overdose or abuse |
| 07/05/2006 | EP1675552A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 07/05/2006 | EP1675551A2 Morinda citrifolia-based oral care compositions and methods |
| 07/05/2006 | EP1675548A2 Rifalazil formulations |
| 07/05/2006 | EP1675465A2 Improved combination bacteriolytic therapy for the treatment of tumors |
| 07/05/2006 | EP1675463A2 Anhydrous silver dihydrogen citrate compositions |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | CN1798831A Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 07/05/2006 | CN1798765A Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/05/2006 | CN1798754A Synthesis of high molecular weight iron-saccharidic complexes |
| 07/05/2006 | CN1798747A Kondensierte pyrazol derivate als protein kinase inhibitoren |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1798579A Targets for tumor growth inhibition |
| 07/05/2006 | CN1798569A Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 07/05/2006 | CN1798502A Method for the treatment of malignancies |
| 07/04/2006 | US7071336 Process for manufacturing opioid analgesics |
| 07/04/2006 | US7071333 Antiinflammatory agents; autoimmune disease; antiarthritic agents; antihistamines; inflammatory bowel disorders; chronic obstructive pulmonary disease; psoriasis |
| 07/04/2006 | US7071234 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 06/29/2006 | WO2005120437A3 Method for treating lupus |
| 06/29/2006 | WO2005110338A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 06/29/2006 | WO2005053615A8 Novel differential imaging method |
| 06/29/2006 | WO2005053615A2 Novel differential imaging method |
| 06/29/2006 | WO2005051315A3 On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
| 06/29/2006 | WO2005051290A8 Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone |
| 06/29/2006 | WO2005041881A8 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |